National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, 14220-14221 [06-2652]

Download as PDF 14220 Federal Register / Vol. 71, No. 54 / Tuesday, March 21, 2006 / Notices A. Federal Reserve Bank of San Francisco (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: 1. The Shen Group, consisting of Bruce Hsiu–I Shen, Su Chin Lin Shen, Sen Fu Shen, Faye Shen, Rancho Palos Verdes, California; Ted Tai–Hsi Shen and Allison Chiang, San Marino, California, and Hsinya Shen, Palo Alto, California; to retain voting shares of American Premier Bancorp, Arcadia, California, and thereby indirectly retain voting shares of American Premier Bank, Arcadia, California. Comments on this application must be received by March 30, 2006. Board of Governors of the Federal Reserve System, March 16, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–4062 Filed 3–20–06; 8:45 am] must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than April 14, 2006. A. Federal Reserve Bank of Chicago (Patrick M. Wilder, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414: 1. Capitol Bancorp, Ltd., Lansing, Michigan; to acquire through its subsidiary, Capitol Bancorp Development Limited, Lansing, Michigan, 51 percent of the voting shares of Sunrise Bank of Atlanta (in organization), Atlanta, Georgia. Board of Governors of the Federal Reserve System, March 16, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–4063 Filed 3–20–06; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM BILLING CODE 6210–01–S Sunshine Act Meeting sroberts on PROD1PC70 with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications VerDate Aug<31>2005 19:01 Mar 20, 2006 Jkt 208001 Board of Governors of the Federal Reserve System. TIME AND DATE: 12 p.m., Monday, March 27, 2006 PLACE: Marriner S. Eccles Federal Reserve Board Building, 20th and C Streets, NW., Washington, DC 20551. STATUS: Closed. MATTERS TO BE CONSIDERED: 1. Personnel actions (appointments, promotions, assignments, reassignments, and salary actions) involving individual Federal Reserve System employees. 2. Any items carried forward from a previously announced meeting. FOR FURTHER INFORMATION CONTACT: Michelle Smith, Director, or Dave Skidmore, Assistant to the Board, Office of Board Members at 202–452–2955. SUPPLEMENTARY INFORMATION: You may call 202–452–3206 beginning at approximately 5 p.m. two business days before the meeting for a recorded announcement of bank and bank holding company applications scheduled for the meeting; or you may contact the Board’s Web site at https:// www.federalreserve.gov for an electronic announcement that not only lists applications, but also indicates procedural and other information about the meeting. AGENCY HOLDING THE MEETING: FEDERAL RESERVE SYSTEM Board of Governors of the Federal Reserve System, March 17, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. 06–2789 Filed 3–17–06; 2:30 pm] BILLING CODE 6210–01–S PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Program Peer Review Subcommittee of the Board of Scientific Counselors (BSC), Centers for Disease Control and Prevention (CDC), National Center for Environmental Health/ Agency for Toxic Substances and Disease Registry (NCEH/ATSDR): Teleconference. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC, NCEH/ATSCR announces the following subcommittee meeting: Name: Program Peer Review Subcommittee (PPRS). Time and Date: 12:30 p.m.–2 p.m. eastern daylight time, April 10, 2006. Place: The teleconference will originate at NCEH/ATSDR in Atlanta, Georgia. To participate, dial (877) 315– 6535 and enter conference code 383520. Purpose: Under the charge of the BSC, NCEH/ATSDR, the PPRS will provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/ATSDR program peer review. They will serve the function of organizing, facilitating, and providing a long-term perspective to the conduct of NCEH/ATSDR program peer review. Matters To Be Discussed: Discussion of the Division of Toxicology and Environmental Medicine Peer Review; an update of the discussion with NCEH/ ATSDR Director on direction of the peer review process; a discussion of the evaluation of the peer review process; and a review of action items from this meeting. Agenda items are subject to change as priorities dictate. FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management Specialist, Office of Science, NCEH/ATSDR, M/S E–28, 1600 Clifton Road, NE., Atlanta, Georgia 30333, telephone (404) 498–0622. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and NCEH/ATSDR. E:\FR\FM\21MRN1.SGM 21MRN1 Federal Register / Vol. 71, No. 54 / Tuesday, March 21, 2006 / Notices Dated: March 14, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–2652 Filed 3–20–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on PROD1PC70 with NOTICES National Center for Environmental Health/Agency for Toxic Substances and Disease Registry The Board of Scientific Counselors, Centers for Disease Control and Prevention (CDC), National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ ATSDR): Meeting. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and NCEH/ ATSDR announce the following committee meeting: Name: Board of Scientific Counselors (BSC), NCEH/ATSDR. Times and Dates: 8 a.m. –4:45 p.m., May 4, 2006. 8 a.m.–12:15 p.m., May 5, 2006. Place: 1825 Century Boulevard, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC, and Administrator, NCEH/ATSDR, are authorized under section 301 (42 U.S.C. 241) and section 311 (42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC, and Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s VerDate Aug<31>2005 19:01 Mar 20, 2006 Jkt 208001 mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Matters To Be Discussed: Items will include but are not limited to a discussion of Fiscal Years 2006 and 2007 budget implications; an update on the peer review of the Air Pollution and Respiratory Health Branch and the Division of Toxicology and Environmental Medicine; a discussion of the Program Peer Review Subcommittee process; updates on the Community and Tribal Subcommittee, the Health Department Subcommittee and the Delisting Workgroup; a discussion on the implications of the Office of Management and Budget Data Quality Guidelines and proposed bulletin on risk assessments; a discussion on the environmental health aspects of pandemic flu planning, the environmental health implications; discussion on future goals, directions, and new priorities; and an introduction of the Goals’ Managers. Agenda items are tentative and subject to change. FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, 1600 Clifton Road, Mail Stop E–28, Atlanta, Georgia 30303; telephone (404) 498–0003, fax (404) 498–0622; E-mail: smalcom@cdc.gov. The deadline for notification of attendance is April 24, 2006. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and NCEH/ATSDR. Dated: March 14, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 06–2653 Filed 3–20–06; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 14221 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Prospective Grant of Exclusive License: Dengue Virus Vaccine Technology Transfer Office, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. ACTION: Notice. AGENCY: SUMMARY: This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention (CDC), Technology Transfer Office, Department of Health and Human Services (DHHS), is contemplating the grant of a worldwide, limited field of use, exclusive license to practice the inventions embodied in the patent application referred to below to Inviragen, LLC, having a place of business in Fort Collins, Colorado. The patent rights in these inventions have been assigned to the government of the United States of America. SUPPLEMENTARY INFORMATION: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), CDC is providing public notice of its intention to grant an exclusive license. CDC will accept written comments concerning this notice for 30 days after publication of this notice. Applications for a license filed in response to this notice will be treated as objections to the grant of the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. A signed Confidential Disclosure Agreement (available under Forms @ https://www.cdc.gov/tto) will be required to receive a copy of any pending patent application. The patent application(s) to be licensed are: PCT/US01/05142 entitled ‘‘Chimeric Dengue Viruses as Candidate Vaccines for Humans,’’ filed February 16, 2001. Status: Received notice of allowance. Issue Date: N/A The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. Technology: This technology provides a new pathway for a dengue virus vaccine. ADDRESSES: Requests for a copy of this patent application, inquiries, comments, and other materials relating to the E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 71, Number 54 (Tuesday, March 21, 2006)]
[Notices]
[Pages 14220-14221]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2652]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Environmental Health/Agency for Toxic 
Substances and Disease Registry

    The Program Peer Review Subcommittee of the Board of Scientific 
Counselors (BSC), Centers for Disease Control and Prevention (CDC), 
National Center for Environmental Health/Agency for Toxic Substances 
and Disease Registry (NCEH/ATSDR): Teleconference.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC, NCEH/ATSCR announces the following 
subcommittee meeting:
    Name: Program Peer Review Subcommittee (PPRS).
    Time and Date: 12:30 p.m.-2 p.m. eastern daylight time, April 10, 
2006.
    Place: The teleconference will originate at NCEH/ATSDR in Atlanta, 
Georgia. To participate, dial (877) 315-6535 and enter conference code 
383520.
    Purpose: Under the charge of the BSC, NCEH/ATSDR, the PPRS will 
provide the BSC, NCEH/ATSDR with advice and recommendations on NCEH/
ATSDR program peer review. They will serve the function of organizing, 
facilitating, and providing a long-term perspective to the conduct of 
NCEH/ATSDR program peer review.
    Matters To Be Discussed: Discussion of the Division of Toxicology 
and Environmental Medicine Peer Review; an update of the discussion 
with NCEH/ATSDR Director on direction of the peer review process; a 
discussion of the evaluation of the peer review process; and a review 
of action items from this meeting.
    Agenda items are subject to change as priorities dictate.

FOR FURTHER INFORMATION CONTACT: Sandra Malcom, Committee Management 
Specialist, Office of Science, NCEH/ATSDR, M/S E-28, 1600 Clifton Road, 
NE., Atlanta, Georgia 30333, telephone (404) 498-0622.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and NCEH/ATSDR.


[[Page 14221]]


    Dated: March 14, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 06-2652 Filed 3-20-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.